Stock listing
ULGX Stock Price, News, Filings & Events — Urologix
Selected listing: ULGX · OTC · USD · US
This page tracks Urologix's ULGX:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ULGX:OTC. ULGX:OTC is the stock-level entry point for investors researching Urologix, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Urologix is a public company traded under the ticker ULGX in the American market. The company has a market capitalization of approximately $2.18 billion. Urologix specializes in medical devices for the treatment of urological conditions, focusing on innovative solutions to improve patient care.

- Ticker
- ULGX:OTC
- Asset type
- Stock
- Market cap
- $2,182
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- OTC
- Currency
- USD
Urologix ULGX:OTC stock context
This page tracks Urologix's ULGX:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ULGX:OTC. ULGX:OTC is the stock-level entry point for investors researching Urologix, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Urologix is a public company traded under the ticker ULGX in the American market. The company has a market capitalization of approximately $2.18 billion. Urologix specializes in medical devices for the treatment of urological conditions, focusing on innovative solutions to improve patient care.
Latest news from Urologix
Urologix Announces SEC Deregistration
July 9, 2015
Costs for In-Office BPH Therapies Presented at the AUA 2015 Annual Meeting in New Orleans
May 21, 2015
Urologix to Host Its Fiscal Year 2015 Third Quarter Conference Call
May 5, 2015
Urologix Announces Hiring of Chief Financial Officer
March 23, 2015
Urologix Reports Second Quarter Fiscal Year 2015 Results
February 5, 2015
Research Urologix
Urologix investor report
Review AI stock analysis and investor report context for ULGX:OTC.
Urologix company profile
View the public company page for Urologix on 6ix.
Urologix news
Read company news and market updates connected to Urologix.
Urologix investor events
Find investor webinars, events, and replay context for Urologix.